EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integration of in vitro and in silico approaches enables prediction of drug-induced liver injury

René Geci iD, Ahenk Zeynep Sayin, Stephan Schaller, Lars Kuepfer

Archives of Toxicology · 2026-05 · 100 (5) · 2029-2046

DOI: 10.1007/s00204-026-04305-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Toxicology, online erschienen am 17.02.2026. Verfasst von René Geci und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Systems Medicine with Focus on Organ Interaction, University Hospital RWTH Aachen, Aachen, Germany. rgeci@ukaachen.de. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Computer Simulation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum RWTH Aachen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug-induced liver injury (DILI) is a major cause of drug attrition and poses a significant threat to patient safety. However, current preclinical prediction methods, including heuristic screening rules, in vitro assays, machine learning models and animal testing, have serious limitations. Here, we demonstrate that combining in vitro toxicity data (cytotoxicity, mitochondrial toxicity, bile salt export pump (BSEP) inhibition) with pharmacokinetic information enables high DILI predictivity. In a retrospective analysis of 241 drugs, we show that the ratio of their in vivo maximum plasma concentration (Cmax) to their lowest in vitro toxicity strongly correlates with clinical DILI risks, with ROC AUC up to 96%. Then, we show that comparable predictivity (ROC AUC up to 91%) is achievable prospectively when Cmax values are predicted in silico by high-throughput physiologically based kinetic modelling. Dynamic simulations of bile acid perturbations further identify drugs potentially causing DILI specifically through BSEP inhibition, providing additional mechanistic insights. This integrative, mechanistic approach shows enhanced DILI predictivity and interpretability, offering an animal-free alternative for early drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemical and Drug Induced Liver InjuryComputer SimulationHumansATP Binding Cassette Transporter, Subfamily B, Member 11Bile Acids and SaltsAnimalsRetrospective StudiesModels, Biological

Stichwörter der Autor:innen

Bile salt export pump (BSEP)CholestasisDrug-induced liver injury (DILI)HepatotoxicityHigh-throughput PBK modellingNew approach methodologies (NAMs)

Substanzen

ATP Binding Cassette Transporter, Subfamily B, Member 11Bile Acids and SaltsABCB11 protein, human

Autor:innen und Institutionen

  • Institute for Systems Medicine with Focus on Organ Interaction, University Hospital RWTH Aachen, Aachen, Germany. rgeci@ukaachen.de.
  • ESQlabs GmbH, Saterland, Germany. rgeci@ukaachen.de.
  • Institute for Systems Medicine with Focus on Organ Interaction, University Hospital RWTH Aachen, Aachen, Germany.
  • ESQlabs GmbH, Saterland, Germany.

ORCID-Profile: René Geci

Förderung

  • Universitätsklinikum RWTH Aachen

Zitieren

APA

Geci, R., Sayin, A. Z., Schaller, S., & Kuepfer, L. (2026). Integration of in vitro and in silico approaches enables prediction of drug-induced liver injury. Archives of Toxicology, 100(5), 2029-2046. https://doi.org/10.1007/s00204-026-04305-2

Vancouver

Geci R, Sayin AZ, Schaller S, Kuepfer L. Integration of in vitro and in silico approaches enables prediction of drug-induced liver injury. Archives of Toxicology. 2026;100(5):2029-2046. doi:10.1007/s00204-026-04305-2

BibTeX
@article{Geci2026,
  author = {Geci, René and Sayin, Ahenk Zeynep and Schaller, Stephan and Kuepfer, Lars},
  title = {Integration of in vitro and in silico approaches enables prediction of drug-induced liver injury},
  journal = {Archives of Toxicology},
  year = {2026},
  volume = {100},
  number = {5},
  pages = {2029--2046},
  doi = {10.1007/s00204-026-04305-2}
}
Kostenlos starten →